139 related articles for article (PubMed ID: 33636580)
1. Sanguinarine combats hypoxia-induced activation of EphB4 and HIF-1α pathways in breast cancer.
Su Q; Wang J; Wu Q; Ullah A; Ghauri MA; Sarwar A; Chen L; Liu F; Zhang Y
Phytomedicine; 2021 Apr; 84():153503. PubMed ID: 33636580
[TBL] [Abstract][Full Text] [Related]
2. Sanguinarine disrupts the colocalization and interaction of HIF-1α with tyrosine and serine phosphorylated-STAT3 in breast cancer.
Su Q; Wang J; Fan M; Ghauri MA; Ullah A; Wang B; Dai B; Zhan Y; Zhang D; Zhang Y
J Cell Mol Med; 2020 Mar; 24(6):3756-3761. PubMed ID: 32065498
[TBL] [Abstract][Full Text] [Related]
3. Sanguinarine inhibits epithelial-mesenchymal transition via targeting HIF-1α/TGF-β feed-forward loop in hepatocellular carcinoma.
Su Q; Fan M; Wang J; Ullah A; Ghauri MA; Dai B; Zhan Y; Zhang D; Zhang Y
Cell Death Dis; 2019 Dec; 10(12):939. PubMed ID: 31819036
[TBL] [Abstract][Full Text] [Related]
4. A perylene derivative regulates HIF-1α and Stat3 signaling pathways.
Chen H; Guan Y; Yuan G; Zhang Q; Jing N
Bioorg Med Chem; 2014 Feb; 22(4):1496-505. PubMed ID: 24485121
[TBL] [Abstract][Full Text] [Related]
5. Signal transducer and activator of transcription 3 is required for hypoxia-inducible factor-1alpha RNA expression in both tumor cells and tumor-associated myeloid cells.
Niu G; Briggs J; Deng J; Ma Y; Lee H; Kortylewski M; Kujawski M; Kay H; Cress WD; Jove R; Yu H
Mol Cancer Res; 2008 Jul; 6(7):1099-105. PubMed ID: 18644974
[TBL] [Abstract][Full Text] [Related]
6. Decursin promotes HIF-1α proteasomal degradation and immune responses in hypoxic tumour microenvironment.
Ge Y; Yoon SH; Jang H; Jeong JH; Lee YM
Phytomedicine; 2020 Nov; 78():153318. PubMed ID: 32896707
[TBL] [Abstract][Full Text] [Related]
7. Targeting heat shock protein 90 in pancreatic cancer impairs insulin-like growth factor-I receptor signaling, disrupts an interleukin-6/signal-transducer and activator of transcription 3/hypoxia-inducible factor-1alpha autocrine loop, and reduces orthotopic tumor growth.
Lang SA; Moser C; Gaumann A; Klein D; Glockzin G; Popp FC; Dahlke MH; Piso P; Schlitt HJ; Geissler EK; Stoeltzing O
Clin Cancer Res; 2007 Nov; 13(21):6459-68. PubMed ID: 17975158
[TBL] [Abstract][Full Text] [Related]
8. Imperatorin suppresses proliferation and angiogenesis of human colon cancer cell by targeting HIF-1α via the mTOR/p70S6K/4E-BP1 and MAPK pathways.
Mi C; Ma J; Wang KS; Zuo HX; Wang Z; Li MY; Piao LX; Xu GH; Li X; Quan ZS; Jin X
J Ethnopharmacol; 2017 May; 203():27-38. PubMed ID: 28341244
[TBL] [Abstract][Full Text] [Related]
9. HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs).
De Francesco EM; Lappano R; Santolla MF; Marsico S; Caruso A; Maggiolini M
Breast Cancer Res; 2013; 15(4):R64. PubMed ID: 23947803
[TBL] [Abstract][Full Text] [Related]
10. Diallyl trisulfides, a natural histone deacetylase inhibitor, attenuate HIF-1α synthesis, and decreases breast cancer metastasis.
Wei Z; Shan Y; Tao L; Liu Y; Zhu Z; Liu Z; Wu Y; Chen W; Wang A; Lu Y
Mol Carcinog; 2017 Oct; 56(10):2317-2331. PubMed ID: 28574600
[TBL] [Abstract][Full Text] [Related]
11. Cucurbitacin B inhibits the translational expression of hypoxia-inducible factor-1α.
Ma J; Zi Jiang Y; Shi H; Mi C; Li J; Xing Nan J; Wu X; Joon Lee J; Jin X
Eur J Pharmacol; 2014 Jan; 723():46-54. PubMed ID: 24333213
[TBL] [Abstract][Full Text] [Related]
12. IL-6 promotes nuclear translocation of HIF-1α to aggravate chemoresistance of ovarian cancer cells.
Xu S; Yu C; Ma X; Li Y; Shen Y; Chen Y; Huang S; Zhang T; Deng W; Wang Y
Eur J Pharmacol; 2021 Mar; 894():173817. PubMed ID: 33345849
[TBL] [Abstract][Full Text] [Related]
13. β-glucan from Lentinus edodes inhibits breast cancer progression via the Nur77/HIF-1α axis.
Zhang X; Li T; Liu S; Xu Y; Meng M; Li X; Lin Z; Wu Q; Xue Y; Pan Y; Alitongbieke G
Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33245358
[TBL] [Abstract][Full Text] [Related]
14. SOX2 promotes hypoxia-induced breast cancer cell migration by inducing NEDD9 expression and subsequent activation of Rac1/HIF-1α signaling.
Wang Y; Bibi M; Min P; Deng W; Zhang Y; Du J
Cell Mol Biol Lett; 2019; 24():55. PubMed ID: 31462898
[TBL] [Abstract][Full Text] [Related]
15. Digitoxin promotes apoptosis and inhibits proliferation and migration by reducing HIF-1α and STAT3 in KRAS mutant human colon cancer cells.
Mi C; Cao X; Ma K; Wei M; Xu W; Lin Y; Zhang J; Wang TY
Chem Biol Interact; 2022 Jan; 351():109729. PubMed ID: 34717917
[TBL] [Abstract][Full Text] [Related]
16. Curcumol inhibits the expression of programmed cell death-ligand 1 through crosstalk between hypoxia-inducible factor-1α and STAT3 (T705) signaling pathways in hepatic cancer.
Zuo HX; Jin Y; Wang Z; Li MY; Zhang ZH; Wang JY; Xing Y; Ri MH; Jin CH; Xu GH; Piao LX; Ma J; Jin X
J Ethnopharmacol; 2020 Jul; 257():112835. PubMed ID: 32278762
[TBL] [Abstract][Full Text] [Related]
17. Hwanggeumchal sorghum induces cell cycle arrest, and suppresses tumor growth and metastasis through Jak2/STAT pathways in breast cancer xenografts.
Park JH; Darvin P; Lim EJ; Joung YH; Hong DY; Park EU; Park SH; Choi SK; Moon ES; Cho BW; Park KD; Lee HK; Kim MJ; Park DS; Chung IM; Yang YM
PLoS One; 2012; 7(7):e40531. PubMed ID: 22792362
[TBL] [Abstract][Full Text] [Related]
18. Kamebakaurin inhibits the expression of hypoxia-inducible factor-1α and its target genes to confer antitumor activity.
Wang KS; Ma J; Mi C; Li J; Lee JJ; Jin X
Oncol Rep; 2016 Apr; 35(4):2045-52. PubMed ID: 26781327
[TBL] [Abstract][Full Text] [Related]
19. Sanguinarine suppresses basal-like breast cancer growth through dihydrofolate reductase inhibition.
Kalogris C; Garulli C; Pietrella L; Gambini V; Pucciarelli S; Lucci C; Tilio M; Zabaleta ME; Bartolacci C; Andreani C; Giangrossi M; Iezzi M; Belletti B; Marchini C; Amici A
Biochem Pharmacol; 2014 Aug; 90(3):226-34. PubMed ID: 24875448
[TBL] [Abstract][Full Text] [Related]
20. In vivo evidence suggesting reciprocal renal hypoxia-inducible factor-1 upregulation and signal transducer and activator of transcription 3 activation in response to hypoxic and non-hypoxic stimuli.
Nechemia-Arbely Y; Khamaisi M; Rosenberger C; Koesters R; Shina A; Geva C; Shriki A; Klaus S; Rosen S; Rose-John S; Galun E; Axelrod JH; Heyman SN
Clin Exp Pharmacol Physiol; 2013 Apr; 40(4):262-72. PubMed ID: 23384058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]